{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:42:32Z","timestamp":1789573352415,"version":"build-2803163510"},"reference-count":121,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00172","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T05:02:26Z","timestamp":1584507746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review"],"prefix":"10.3389","volume":"11","author":[{"given":"Karen","family":"Van den Houte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emidio","family":"Scarpellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wout","family":"Verbeure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien","family":"Schol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Masuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.3748\/wjg.v12.i17.2661","article-title":"Epidemiology of functional dyspepsia: a global perspective","volume":"12","author":"Mahadeva","year":"2006","journal-title":"World J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2982.2009.01262.x","article-title":"Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings","volume":"21","author":"Piessevaux","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2036.2008.03784.x","article-title":"Meta-analysis: Helicobacter pylori 'test and treat' compared with empirical acid suppression for managing dyspepsia","volume":"28","author":"Ford","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nrgastro.2013.14","article-title":"Functional dyspepsia\u2013symptoms, definitions and validity of the Rome III criteria","volume":"10","author":"Tack","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/apt.12355","article-title":"Functional dyspepsia: the economic impact to patients","volume":"38","author":"Lacy","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/j.1365-2036.2011.04640.x","article-title":"Functional dyspepsia impairs quality of life in the adult population","volume":"33","author":"Aro","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1365-2036.2003.01706.x","article-title":"Health-related quality of life in functional dyspepsia","volume":"18","author":"El-Serag","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/PSY.0b013e31822f32bf","article-title":"Abuse history, depression, and somatization are associated with gastric sensitivity and gastric emptying in functional dyspepsia","volume":"73","author":"Van Oudenhove","year":"2011","journal-title":"Psychosom Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrgastro.2012.253","article-title":"Overlap of functional dyspepsia and GERD\u2013diagnostic and treatment implications","volume":"10","author":"Quigley","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/nmo.12377","article-title":"Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community","volume":"26","author":"Pleyer","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"B14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coph.2018.08.015","article-title":"New developments in the treatment of gastroparesis and functional dyspepsia","volume":"43","author":"Tack","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2013-306084","article-title":"Gastroparesis: separate entity or just a part of dyspepsia?","volume":"63","author":"Stanghellini","year":"2014","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrgastro.2011.116","article-title":"Gastroparesis: pathogenesis, diagnosis and management","volume":"8","author":"Hasler","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/MCG.0000000000000972","article-title":"Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013","volume":"53","author":"Hirsch","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders: disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gutjnl-2016-312361","article-title":"Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts","volume":"67","author":"Simr\u00e9n","year":"2018","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.cgh.2016.12.032","article-title":"Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population","volume":"15","author":"Jones","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/17474124.2019.1543586","article-title":"Postprandial distress syndrome: stratification and management","volume":"13","author":"Van Den Houte","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.gastro.2013.05.018","article-title":"In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity","volume":"145","author":"Farr\u00e9","year":"2013","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","article-title":"A diet low in FODMAPs reduces symptoms of irritable bowel syndrome","volume":"146","author":"Halmos","year":"2014","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.gastro.2019.03.046","article-title":"Many patients with irritable bowel syndrome have atypical food allergies not associated with immunoglobulin E","volume":"157","author":"Fritscher-Ravens","year":"2019","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ajg.2013.24","article-title":"Food and symptom generation in functional gastrointestinal disorders: physiological aspects","volume":"108","author":"Farr\u00e9","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/gutjnl-2013-305112","article-title":"Taste receptors of the gut: emerging roles in health and disease","volume":"63","author":"Depoortere","year":"2014","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/ajg.2014.330","article-title":"Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia","volume":"109","author":"Bharucha","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/gut.2007.137125","article-title":"Relationship between symptoms and ingestion of a meal in functional dyspepsia","volume":"57","author":"Bisschops","year":"2008","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/gut.2005.089508","article-title":"Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction?","volume":"56","author":"Karamanolis","year":"2007","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00006842-199805000-00020","article-title":"Gastrin, cholecystokinin, and somatostatin in a laboratory experiment of patients with functional dyspepsia","volume":"60","author":"Jonsson","year":"1998","journal-title":"Psychosom Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3748\/wjg.v11.i3.443","article-title":"Gastrointestinal hormone abnormalities and G and D cells in functional dyspepsia patients with gastric dysmotility","volume":"11","author":"He","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B32","first-page":"362","article-title":"[Gastrin secretion in patients with functional dyspepsia]","volume":"26","author":"Walecka-Kapica","year":"2009","journal-title":"Pol Merkur Lekarski"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1046\/j.1365-2036.2002.01352.x","article-title":"Serum pepsinogen can predict response to H2-receptor antagonist in patients with functional dyspepsia","volume":"16","author":"Yoshikawa","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MCG.0000000000000531","article-title":"Gastric activity and gut peptides in patients with functional dyspepsia: postprandial distress syndrome versus epigastric pain syndrome","volume":"51","author":"Russo","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000093485","article-title":"Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects","volume":"77","author":"Katagiri","year":"2006","journal-title":"Pharmacology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gut.52.11.1555","article-title":"Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans","volume":"52","author":"Foxx-Orenstein","year":"2003","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3892\/ijmm.2013.1418","article-title":"The role of ghrelin in patients with functional dyspepsia and its potential clinical relevance (Review)","volume":"32","author":"Yagi","year":"2013","journal-title":"Int J Mol Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3748\/wjg.v18.i18.2231","article-title":"Plasma levels of acylated ghrelin in patients with functional dyspepsia","volume":"18","author":"Kim","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000205740","article-title":"Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease","volume":"79","author":"Shindo","year":"2009","journal-title":"Digestion"},{"key":"B40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/01.mcg.0000225614.94470.47","article-title":"Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia","volume":"41","author":"Takamori","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1111\/j.1365-2036.2006.00032.x","article-title":"Enhanced plasma ghrelin levels in patients with functional dyspepsia","volume":"24","author":"Nishizawa","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1111\/j.1572-0241.2008.02041.x","article-title":"Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY","volume":"103","author":"Pilichiewicz","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-07-0768","article-title":"Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite","volume":"158","author":"Akamizu","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5754\/hge11246","article-title":"Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin","volume":"59","author":"Arai","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/nmo.12348","article-title":"Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia\u2013a multicenter, double-blind, randomized, placebo-controlled study","volume":"26","author":"Suzuki","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s10620-005-9022-z","article-title":"Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis","volume":"51","author":"Gaddipati","year":"2006","journal-title":"Dig Dis Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2036.2005.02658.x","article-title":"Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis","volume":"22","author":"Tack","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gut.2005.069088","article-title":"Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study","volume":"54","author":"Murray","year":"2005","journal-title":"Gut"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.peptides.2005.12.008","article-title":"Ghrelin gastrokinetic action in patients with neurogenic gastroparesis","volume":"27","author":"Binn","year":"2006","journal-title":"Peptides"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1365-2036.2009.03986.x","article-title":"Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis","volume":"29","author":"Ejskjaer","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00134-019-05593-2","article-title":"A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial","volume":"45","author":"Heyland","year":"2019","journal-title":"Intensive Care Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1111\/nmo.12064","article-title":"A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis","volume":"25","author":"Ejskjaer","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1111\/nmo.12184","article-title":"Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis","volume":"25","author":"McCallum","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"B54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.gastro.2016.03.038","article-title":"Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1053\/j.gastro.2017.07.035","article-title":"Efficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, Placebo-Controlled Study","volume":"153","author":"Camilleri","year":"2017","journal-title":"Gastroenterology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0016-5085(86)90069-7","article-title":"Interdigestive gastroduodenal motility and serum motilin levels in patients with idiopathic delay in gastric emptying","volume":"90","author":"Labo","year":"1986","journal-title":"Gastroenterology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0016-5085(85)90512-8","article-title":"Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: effect of metoclopramide","volume":"88","author":"Achem-Karam","year":"1985","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","article-title":"Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial","volume":"14","author":"Talley","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/gut.49.3.395","article-title":"Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial","volume":"49","author":"Talley","year":"2001","journal-title":"Gut"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1365-2036.2007.03461.x","article-title":"Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study","volume":"26","author":"McCallum","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2036.2007.03346.x","article-title":"Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial","volume":"26","author":"McCallum","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"B62","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1572-0241.2005.00339.x","article-title":"Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways","volume":"101","author":"Cuomo","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e13173","DOI":"10.1111\/nmo.13173","article-title":"Manometric evaluation of the motilin receptor agonist camicinal (GSK962040) in humans","volume":"30","author":"Deloose","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/bph.13475","article-title":"The pharmacodynamics, safety, and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying","volume":"173","author":"Hellstr\u00f6m","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/S0016-5085(14)60070-6","article-title":"A randomized, double-blind, placebo-controlled phase II study (MOT114479) to evaluate the safety and efficacy and dose response of 28 days of orally administered camicinal, a motilin receptor agonist, in diabetics with gastroparesis","volume":"146","author":"Barton","year":"2014","journal-title":"Gastroenterology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13054-016-1420-4","article-title":"The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial","volume":"20","author":"Chapman","year":"2016","journal-title":"Crit Care"},{"key":"B67","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1023\/A:1005601623363","article-title":"Effect of Helicobacter pylori infection on gastric emptying and gastrointestinal hormones in dyspeptic and healthy subjects","volume":"46","author":"Chiloiro","year":"2001","journal-title":"Dig Dis Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/00042737-199511000-00007","article-title":"Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia","volume":"7","author":"Barbera","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/gut.48.3.347","article-title":"Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia","volume":"48","author":"Feinle","year":"2001","journal-title":"Gut"},{"key":"B70","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/MEG.0000000000000001","article-title":"Functional dyspepsia patients have lower mucosal cholecystokinin concentrations in response to duodenal lipid","volume":"26","author":"van Boxel","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/gut.52.10.1414","article-title":"Role of cognitive factors in symptom induction following high and low fat meals in patients with functional dyspepsia","volume":"52","author":"Feinle-Bisset","year":"2003","journal-title":"Gut"},{"key":"B72","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/apt.15195","article-title":"Randomised clinical trial: the DPP-4 inhibitor, vildagliptin, inhibits gastric accommodation and increases glucagon-like peptide-1 plasma levels in healthy volunteers","volume":"49","author":"Rotondo","year":"2019","journal-title":"Ent Pharmacol Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.nut.2017.08.007","article-title":"Effects of three major amino acids found in Japanese broth on glucose metabolism and gastric emptying","volume":"46","author":"Mano","year":"2018","journal-title":"Nutrition"},{"key":"B74","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/00365521.2015.1101780","article-title":"Peptide YY3-36 and glucagon-like peptide-1 in functional dyspepsia. Secretion and role in symptom generation","volume":"51","author":"Witte","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1046\/j.1365-2036.1998.00366.x","article-title":"Influence of cisapride on gastric tone and on the perception of gastric distension","volume":"12","author":"Tack","year":"1998","journal-title":"Alim Pharmacol Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/nmo.12359","article-title":"Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects","volume":"26","author":"Kessing","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nmo.12411","article-title":"The effect of prucalopride on gastric accommodation in healthy volunteers","volume":"26","author":"Carbone","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"B78","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1365-2036.2002.01152.x","article-title":"Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?","volume":"16","author":"Netzer","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"B79","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1365-2982.2010.01655.x","article-title":"Influence of the 5-HT(3) receptor antagonist ondansetron on gastric sensorimotor function and nutrient tolerance in healthy volunteers","volume":"23","author":"Janssen","year":"2011","journal-title":"Neurogastroenterol Motil"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1365-2036.2008.03849.x","article-title":"Influence of buspirone on gastric sensorimotor function in man","volume":"28","author":"Van Oudenhove","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","article-title":"Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia","volume":"10","author":"Tack","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"G228","DOI":"10.1152\/ajpgi.00020.2010","article-title":"Influence of acute tryptophan depletion on gastric sensorimotor function in humans","volume":"300","author":"Geeraerts","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","article-title":"Influence of the selective serotonin reuptake inhibitor paroxetine on gastric sensorimotor function in man","volume":"17","author":"Tack","year":"2003","journal-title":"Alim Pharmacol Ther"},{"key":"B84","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2036.2010.04522.x","article-title":"The effects of acute citalopram dosing on gastric motor function and nutrient tolerance in healthy volunteers","volume":"33","author":"Janssen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"B85","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2036.2010.04351.x","article-title":"The influence of citalopram on interdigestive gastrointestinal motility in man","volume":"32","author":"Janssen","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B86","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0016-5085(93)90895-J","article-title":"5-Hydroxytryptamine3 receptors are involved in the initiation of gastric phase 3 motor activity in man","volume":"105","author":"Wilmer","year":"1993","journal-title":"Gastroenterology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cgh.2013.03.026","article-title":"Decreased Basal and postprandial plasma serotonin levels in patients with functional dyspepsia","volume":"11","author":"Cheung","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"B89","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jcem.87.1.8129","article-title":"Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion","volume":"87","author":"Shiiya","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tsch\u00f6p","year":"2001","journal-title":"Diabetes"},{"key":"B91","first-page":"1249","article-title":"Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I\/II ratio\u2013a possible novel and non-invasive marker for gastric atrophy","volume":"51","author":"Suzuki","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00535-009-0120-0","article-title":"Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis","volume":"44","author":"Kawashima","year":"2009","journal-title":"J Gastroenterol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000215389","article-title":"Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia","volume":"80","author":"Lee","year":"2009","journal-title":"Digestion"},{"key":"B94","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/00365520510015403","article-title":"Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients","volume":"40","author":"Shinomiya","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrgastro.2012.57","article-title":"The migrating motor complex: control mechanisms and its role in health and disease","volume":"9","author":"Deloose","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/gut.42.2.235","article-title":"Prolonged ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms and gastric emptying","volume":"42","author":"Wilmer","year":"1998","journal-title":"Gut"},{"key":"B97","doi-asserted-by":"publisher","first-page":"G776","DOI":"10.1152\/ajpgi.00456.2002","article-title":"Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers","volume":"284","author":"Kamerling","year":"","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1507\/endocrj1954.27.Supplement_151","article-title":"Plasma motilin levels in normal subjects and patients with diabetes mellitus and certain other diseases. Fasting levels and responses to food and glucose","volume":"27","author":"Imura","year":"1980","journal-title":"Endocrinol Jpn"},{"key":"B99","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/gutjnl-2014-308472","article-title":"Motilin-induced gastric contractions signal hunger in man","volume":"65","author":"Tack","year":"2016","journal-title":"Gut"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJM199004123221502","article-title":"Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies","volume":"322","author":"Janssens","year":"1990","journal-title":"N Engl J Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/gut.2003.035279","article-title":"Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying","volume":"54","author":"Arts","year":"2005","journal-title":"Gut"},{"key":"B102","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5056\/jnm.2010.16.4.407","article-title":"Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis","volume":"16","author":"Larson","year":"2010","journal-title":"J Neurogastroenterol Motil"},{"key":"B103","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/gut.49.3.317","article-title":"What comes after macrolides and other motilin stimulants?","volume":"49","author":"Tack","year":"2001","journal-title":"Gut"},{"key":"B104","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2036.2004.02066.x","article-title":"Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis","volume":"20","author":"Russo","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3748\/wjg.v12.i9.1329","article-title":"Role of cholecystokinin and central serotonergic receptors in functional dyspepsia","volume":"12","author":"Chua","year":"2006","journal-title":"World J Gastroenterol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"i54","DOI":"10.1136\/gut.51.suppl_1.i54","article-title":"The role of fat and cholecystokinin in functional dyspepsia","volume":"51","author":"Fried","year":"2002","journal-title":"Gut"},{"key":"B107","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0928-4257(93)90035-R","article-title":"Effect of CCK and its antagonists on gastric emptying","volume":"87","author":"Scarpignato","year":"1993","journal-title":"J Physiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.3748\/wjg.v12.i17.2688","article-title":"Cholecystokinin hyperresponsiveness in functional dyspepsia","volume":"12","author":"Chua","year":"2006","journal-title":"World J Gastroenterol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/0016-5085(85)90211-2","article-title":"Human distribution and release of a putative new gut hormone, peptide YY","volume":"89","author":"Adrian","year":"1985","journal-title":"Gastroenterology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signalling system: from basic understanding to drug development for functional GI disorders","volume":"219","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"G260","DOI":"10.1152\/ajpgi.00056.2008","article-title":"Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants","volume":"295","author":"Kidd","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","article-title":"Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome","volume":"3","author":"Dunlop","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"204","DOI":"10.14309\/ajg.0000000000000072","article-title":"The unfulfilled promise of prokinetics for functional dyspepsia\/postprandial distress syndrome","volume":"114","author":"Tack","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1046\/j.1365-2036.2002.01236.x","article-title":"Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study","volume":"16","author":"Hallerback","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/nmo.12736","article-title":"Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis","volume":"28","author":"Tack","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"B117","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5114\/aoms.2017.69234","article-title":"Efficacy of serotonin receptor agonists in the treatment of functional dyspepsia: a meta-analysis","volume":"15","author":"Jin","year":"2019","journal-title":"Arch Med Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.14309\/ajg.0000000000000304","article-title":"Prucalopride in gastroparesis: a randomized placebo-controlled crossover study","volume":"114","author":"Carbone","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1016\/S0016-5085(19)37201-4","article-title":"Velusetrag improves gastroparesis both in symptoms and gastric emptying in patients with diabetic or idiopathic gastroparesis in a 12-week global phase 2B study","volume":"156","author":"Abell","year":"2019","journal-title":"Gastroenterology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5056\/jnm15203","article-title":"Granisetron transdermal system for treatment of symptoms of gastroparesis: a prescription registry study","volume":"22","author":"Midani","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s10620-014-3097-3","article-title":"Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis","volume":"59","author":"Simmons","year":"2014","journal-title":"Dig Dis Sci"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00172\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T05:02:30Z","timestamp":1584507750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00172\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":121,"alternative-id":["10.3389\/fpsyt.2020.00172"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00172","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"article-number":"172"}}